|
Name |
Chrysophanol
|
Molecular Formula | C15H10O4 | |
IUPAC Name* |
1,8-dihydroxy-3-methylanthracene-9,10-dione
|
|
SMILES |
CC1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=CC=C3O
|
|
InChI |
InChI=1S/C15H10O4/c1-7-5-9-13(11(17)6-7)15(19)12-8(14(9)18)3-2-4-10(12)16/h2-6,16-17H,1H3
|
|
InChIKey |
LQGUBLBATBMXHT-UHFFFAOYSA-N
|
|
Synonyms |
Chrysophanol; 481-74-3; CHRYSOPHANIC ACID; 1,8-Dihydroxy-3-methylanthraquinone; 3-Methylchrysazin; Turkey rhubarb; 1,8-dihydroxy-3-methylanthracene-9,10-dione; C.I. Natural Yellow 23; NSC 37132; 1,8-Dihydroxy-3-methyl-9,10-anthracenedione; NSC 646567; Crysophanic acid; 4,5-Dihydroxy-2-methylanthraquinone; Crysophanol; 2-Methyl-4,5-dihydroxyanthraquinone; 3-Methyl-1,8-dihydroxyanthraquinone; C.I. 75400; 1,8-Dihydroxy-3-Methyl-Anthraquinone; CHEBI:3687; NSC-37132; NSC-646567; N1ST8V8RR2; Anthraquinone, 1,8-dihydroxy-3-methyl-; Chrysophanic acid (1,8-dihydroxy-3-methylanthraquinone); 1,8-dihydroxy-3-methyl-9,10-anthraquinone; 1,8-Dihydroxy-3-methylanthra-9,10-quinone; 9,10-Anthracenedione, 1,8-dihydroxy-3-methyl-; NSC646567; CCRIS 3525; EINECS 207-572-2; UNII-N1ST8V8RR2; Archinin; Rumicin; Chrysophansaeure; MFCD00001208; Spectrum_000792; Chrysophanic Acid,(S); SpecPlus_000321; Spectrum2_000043; Spectrum3_001183; Spectrum4_001477; Spectrum5_000153; DSSTox_CID_4832; 1,8-dihydroxy-3-methyl-anthracene-9,10-dione; DSSTox_RID_77547; DSSTox_GSID_24832; BSPBio_002825; KBioGR_002053; KBioSS_001272; SPECTRUM300545; MLS000574888; CHEMBL41092; DivK1c_006417; SCHEMBL308131; SPBio_000165; CHRYSOPHANIC ACID [MI]; 9, 1,8-dihydroxy-3-methyl-; Chrysophanic acid (Chrysophanol); Chrysophanic acid - Chrysophanol; DTXSID6024832; Chrysophanol, analytical standard; HSDB 8483; KBio1_001361; KBio2_001272; KBio2_003840; KBio2_006408; KBio3_002325; HMS3656G17; CHRYSOPHANIC ACID [WHO-DD]; BCP23439; EX-A6777; NSC37132; ZINC3861630; Tox21_202499; Anthraquinone,8-dihydroxy-3-methyl-; BDBM50455992; CCG-38348; LMPK13040006; s2406; STL564344; 3-Methyl-1, 8-dihydroxyanthraquinone; 4, 5-Dihydroxy-2-methylanthraquinone; AKOS015905000; AC-7980; BCP9000004; DS-9706; SDCCGMLS-0066504.P001; NCGC00091823-01; NCGC00091823-02; NCGC00091823-03; NCGC00091823-04; NCGC00091823-05; NCGC00260048-01; CAS-481-74-3; HY-13595; SMR000156239; 1,8-Dihydroxy-3-methylanthraquinone, 98%; 8,9-dihydroxy-6-methyl-1,10-anthraquinone; FT-0623813; SW219732-1; 1,8-Dihydroxy-3-methylanthra-9,10-quinone #; EN300-7401332; 481C743; A827496; N-(diaminomethylene)formamide;3-METHYLCHRYSAZIN; SR-01000712223; 1,8-Dihydroxy-3-methyl-9,10-anthracenedione, 9CI; Q-100527; SR-01000712223-2; BRD-K59284035-001-02-0; BRD-K59284035-001-03-8; Q15410875; 9,10-Anthracenedione, 1,8-dihydroxy-3-methyl- (9CI); 1,8-DIHYDROXY-3-METHYL-9,10-DIHYDROANTHRACENE-9,10-DIONE
|
|
CAS | 481-74-3 | |
PubChem CID | 10208 | |
ChEMBL ID | CHEMBL41092 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 254.24 | ALogp: | 3.5 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 74.6 | Aromatic Rings: | 3 |
Heavy Atoms: | 19 | QED Weighted: | 0.646 |
Caco-2 Permeability: | -4.936 | MDCK Permeability: | 0.00001400 |
Pgp-inhibitor: | 0.034 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.009 | 20% Bioavailability (F20%): | 0.064 |
30% Bioavailability (F30%): | 0.998 |
Blood-Brain-Barrier Penetration (BBB): | 0.135 | Plasma Protein Binding (PPB): | 99.64% |
Volume Distribution (VD): | 0.457 | Fu: | 0.83% |
CYP1A2-inhibitor: | 0.954 | CYP1A2-substrate: | 0.411 |
CYP2C19-inhibitor: | 0.279 | CYP2C19-substrate: | 0.06 |
CYP2C9-inhibitor: | 0.636 | CYP2C9-substrate: | 0.402 |
CYP2D6-inhibitor: | 0.537 | CYP2D6-substrate: | 0.228 |
CYP3A4-inhibitor: | 0.599 | CYP3A4-substrate: | 0.138 |
Clearance (CL): | 6.205 | Half-life (T1/2): | 0.137 |
hERG Blockers: | 0.027 | Human Hepatotoxicity (H-HT): | 0.046 |
Drug-inuced Liver Injury (DILI): | 0.942 | AMES Toxicity: | 0.886 |
Rat Oral Acute Toxicity: | 0.23 | Maximum Recommended Daily Dose: | 0.807 |
Skin Sensitization: | 0.517 | Carcinogencity: | 0.908 |
Eye Corrosion: | 0.006 | Eye Irritation: | 0.98 |
Respiratory Toxicity: | 0.072 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000094 | 0.683 | D0N1FS | 0.420 | ||||
ENC004888 | 0.672 | D03GET | 0.354 | ||||
ENC000087 | 0.672 | D07MGA | 0.329 | ||||
ENC000362 | 0.652 | D04AIT | 0.310 | ||||
ENC000939 | 0.603 | D0Y7PG | 0.309 | ||||
ENC002031 | 0.580 | D0K8KX | 0.302 | ||||
ENC002125 | 0.576 | D0H6QU | 0.298 | ||||
ENC005490 | 0.541 | D0H1AR | 0.295 | ||||
ENC005573 | 0.524 | D0H2ZW | 0.284 | ||||
ENC005572 | 0.524 | D0R3JB | 0.279 |